Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

'Big Short' Investor Michael Burry Ditches Gold, US Stocks For Cheap Chinese Internet Companies

Burry reduced Scion Asset Management's portfolio size by almost half in Q2 to just over $50 million as part of a reshuffling that involves investments in healthcare and China's tech firms.

International Business Times UK

Inside Bavarian Nordic: The $3.3 billion Danish vaccine maker with the world's only cure for mpox

Amid a new strain of mpox, the Danish company is preparing to make millions of vaccine doses to supply to the world.

Fortune

How much caffeine is too much?

Although caffeine has its benefits, too much can be detrimental to your health. In fact, it can exacerbate existing conditions.

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

The FDA Just Approved Another At-Home Test For STIs — This One For Syphilis

The Food and Drug Administration approves the first at-home test for the sexually transmitted infection syphilis, which has been on the rise since 2018.

Inverse

3 'Strong Buy' Small-Cap Stocks to Snag Now for a Soft Landing

Explore three small-cap stocks with 'Strong Buy' ratings that are poised for significant growth as economic conditions hint at a potential soft landing.

Barchart

The FDA just cleared 'Traumagel,' a wound-treating gel with 'the color and texture of hummus' that sounds like a real-life FPS medkit

Get Master Chief one of these, stat.

PC Gamer

The Future of Psychedelic Research Is In Limbo — Why the FDA’s Decision Changed Everything

The FDA just rejected MDMA-assisted therapy for PTSD. What's next for psychedelic drugs in science and everyday life?

Inverse

Read news from The Economist, FT, and more,
with one subscription

FDA Wants To Further Reduce Salt Levels In Packaged, Processed Food

After the successful execution of the Phase I target, the FDA plans to further reduce sodium levels by 20%, to bring the average intake to about 2,750 milligrams per day.

Medical Daily

Nearly 450 people have fallen ill with Salmonella linked to recalled cucumbers

More than 100 people were hospitalized, health officials say

The Independent UK

Study: Sweetener linked to blood clots

This follows a 2023 study which also linked the artificial sweetener to "stroke, heart attack and death"

Salon

What caused the listeria outbreak?

"Some of the worst food safety failures happen when the duties of multiple agencies overlap . . ."

Salon

Christina Aguilera reflects on public scrutiny over her weight amid Ozempic rumors

‘Other people’s opinions of me are not my business,’ singer says

The Independent UK

Google Pixel Watch 3 vs. Samsung Galaxy Watch 7: which Android smartwatch should you buy?

Google Pixel Watch 3 vs. Samsung Galaxy Watch 7: Which Android smartwatch should you get? We have answers.

Tom’s Guide

A Single Episode Of Shingles Raises Cognitive Decline By 20%, Says Study

The pain and complications of shingles do not end with the episode, as a new study suggests that its impact could be long-term.

Medical Daily

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading.

The Independent UK

What is Neffy? FDA approves first nasal spray to treat severe allergies

Neffy, the first single-dose nasal spray approved to treat severe allergies, will hit the market in a matter of weeks

Tom’s Guide

Google Pixel Watch 3 is first smartwatch with pulse loss detection — here’s how it works

Google introduced a new pulse loss detection feature coming to the newly announced Pixel Watch 3 lineup.

The Conversation

FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face

Drugmaker Lykos Therapeutics announced on Aug. 9, 2024, that the Food and Drug Administration declined to approve the company’s application for the use of MDMA-assisted therapy in the treatment of post-traumatic stress disorder. It is the first such decision issued on a psychedelic drug application.

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

FDA approves 1st needle-free alternative to EpiPens

There's now an option to treat anaphylaxis via a nasal spray, rather than with an auto-injected medication.

Reason

Tim Walz Is Another Big-Government Liberal

Plus: A listener asks the editors about tariffs and subsidies in the manufacture of electric vehicles.

StockNews.com

3 Blue-Chip Dividend Stocks for a Secure Retirement Portfolio

Blue-chip dividend stocks are of well-established companies offering steady income and financial stability. They are ideal for securing a resilient retirement portfolio, combining consistent dividends with potential capital appreciation. Thus, quality blue-chip dividend stocks Johnson & Johnson (JNJ), Coca-Cola (KO), and McDonald’s (MCD) could be ideal portfolio additions for retirement…

Reason

FDA Declines To Approve MDMA-Assisted Psychotherapy As a PTSD Treatment

The FDA, which approved the protocols for the studies it now questions, is asking for an additional Phase 3 clinical trial, which would take years and millions of dollars.

Roll Call

FDA rejects MDMA therapy for treatment of PTSD. What’s next? - Roll Call

The Food and Drug Administration declined to approve MDMA as the first psychedelic drug used to treat post-traumatic stress disorder.

Medical Daily

Neffy: Know All About First FDA Approved Nasal Spray To Treat Severe Allergic Reactions

The new treatment, a needle-free alternative, could be used for managing severe allergic responses in children and adults, weighing at least 66 pounds, the FDA said.

Top News

JD Vance Supports State Decision-Making On Abortion Policy

JD Vance supports state autonomy in abortion policy, advocating for varied regulations based on state decisions.

1 … 99 100 101 102

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.